OUE Healthcare Limited AGM 2026: Key Highlights and Investor Insights
Date: 24 April 2026
Location: Hilton Singapore Orchard, Grand Ballroom
Key Points from the AGM
-
Strategic Progress and Growth Initiatives:
- The CEO presented an update on the company’s progress since 2018, anchored on a three-pronged strategy: asset-light operations, strategic partnerships, and regional expansion in Asia.
- OUE Healthcare is moving towards specialized care and plans to launch an integrative medicine service combining traditional and Western medicine, aiming to create value for stakeholders through innovation and adaptation to dynamic market conditions.
-
Board Changes:
- Three Independent Directors—Mr Roger Tan Chade Phang, Mr Eric Sho Kian Hin, and Mr Jackson Tay Eng Kiat—retired from the Board as of the AGM’s conclusion.
- The Board formally thanked them for their invaluable contributions.
-
Operational Resilience & Regional Assets:
- The Group’s flagship Pun Hlaing Hospital in Yangon, Myanmar, achieved Joint Commission International (JCI) accreditation, highlighting the Group’s operational strength in challenging markets.
- In Singapore, OUE Healthcare has formed one of the largest private specialist groups in cardiothoracic surgery and respiratory medicine, and launched a state-of-the-art, suite-only Cura day surgery centre.
- The company continues to seek opportunities to acquire new hospitals and create synergies between Singapore and other regions.
-
Asset Valuation and Shareholder Value:
- Some overseas assets are held via joint ventures and associates, and are not consolidated on the balance sheet, which may lead to an underappreciation of the company’s true value.
- The CEO noted that the current share price does not fully reflect the Group’s intrinsic value, partly due to a small free float.
-
Potential Special Dividend and Privatisation Talk:
- Shareholders raised the potential for a special dividend from First REIT’s proposed divestment. The CEO advised that plans will be evaluated once First REIT unitholders vote in June 2026.
- A shareholder suggested that OUE Limited, which owns close to 90% of OUE Healthcare, should privatize the company. The Board stated that any privatization would be subject to OUE Limited’s decision and would be evaluated if an offer is made.
-
Voting Results on Key Resolutions:
- Resolution 1 (Adoption of FY2025 Financial Statements): Passed with 100% approval.
- Resolution 2 (Directors’ Fees of S\$618,801.37 for FY2025): Passed with 100% approval.
- Resolution 3 (Re-appointment of KPMG LLP as Auditors): Passed with 100% approval.
- Resolution 4 (General Share Issue Mandate): Passed, authorizing directors to issue shares up to 100% of issued share capital, with up to 50% on a non pro-rata basis.
Potential Price-Sensitive Developments
- First REIT Divestment and Special Dividend: If First REIT’s proposed asset divestment is approved, OUE Healthcare may receive a significant cash inflow, possibly leading to a special dividend or new investment opportunities. Investors should monitor the outcome of First REIT’s EGM in June 2026 as this could directly impact OUE Healthcare’s financial position and share value.
- Privatization Possibility: With OUE Limited holding close to 90% of shares, any move towards privatization could trigger a buyout offer, potentially at a premium to the current market price. No concrete plans have been announced, but the high ownership concentration remains a key point for investors.
- Asset Valuation Disclosure: The company’s assets in overseas joint ventures and associates are not reflected on the consolidated balance sheet, which may mean the company is undervalued relative to its true asset base.
- Expansion and Strategic Partnerships: The company’s ongoing expansion in both Singapore and the region, especially into specialized and integrative care, could enhance revenue streams and market positioning, supporting long-term value creation.
Other Notable Information for Shareholders
- Voting at the AGM was conducted by poll via paperless handheld devices, enhancing transparency and efficiency.
- No advance or on-the-day questions from shareholders were received, indicating either satisfaction with disclosures or a passive investor base.
- The minutes of the AGM will be published on SGXNET and the company’s website for transparency.
Conclusion
OUE Healthcare Limited continues to position itself for growth through strategic partnerships, regional expansion, and innovation in specialized healthcare services. The potential for a special dividend from First REIT’s divestment and the possibility of privatization by OUE Limited are key issues for investors to watch in the coming months. The company’s asset-light approach and strong operational track record in challenging markets provide a foundation for further value creation.
Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors should perform their own due diligence and consult professional advisors before making investment decisions.
OUE Healthcare Limited 2026年度股东大会：要点摘要及投资者视角
日期：2026年4月24日
地点：新加坡希尔顿乌节路酒店，宴会厅
大会要点
-
战略进展与增长举措：
- 首席执行官回顾了自2018年以来的进展，聚焦轻资产运营、战略合作及亚洲区域扩张三大策略。
- 公司正推进向专科医疗转型，并计划推出结合中西医的综合医疗服务，旨在通过创新和适应市场变化为利益相关者创造价值。
-
董事会变动：
- 三位独立董事（Roger Tan Chade Phang、Eric Sho Kian Hin、Jackson Tay Eng Kiat）于本次大会后退休。
- 董事会对他们的宝贵贡献表示感谢。
-
运营韧性与区域资产：
- 集团在缅甸仰光的旗舰医院Pun Hlaing Hospital获得JCI国际认证，显示集团在复杂市场下的运营实力。
- 在新加坡，公司已组建本地最大心胸外科及呼吸专科集团之一，并设立了先进的Cura日间手术中心。
- 集团将持续寻求并购新医院，打造新加坡与区域协同效应。
-
资产估值与股东价值：
- 部分海外资产通过合资企业和联营公司持有，未并入资产负债表，可能低估公司实际价值。
- CEO指出，由于流通股本较小，当前股价未能充分反映集团内在价值。
-
特别股息及私有化讨论：
- 股东关注First REIT资产出售后可能带来的特别股息。CEO表示需待First REIT持有人6月表决后再评估资金用途。
- 有股东建议大股东OUE Limited（持股近90%）将公司私有化。董事会表示，若有正式要约，将予以评估。
-
主要议案表决结果：
- 议案1（采纳2025年报表）： 100%通过。
- 议案2（2025年董事费S\$618,801.37）： 100%通过。
- 议案3（KPMG LLP续任审计师）： 100%通过。
- 议案4（增发股份授权）： 100%通过，授权董事可发行不超过已发行股本100%的新股，其中最多50%可非按比例发行。
潜在价格敏感信息
- First REIT出售及特别股息： 若First REIT资产出售获批，OUE Healthcare可能获得大额现金流，并有机会派发特别股息或进行新投资，建议投资者关注6月First REIT特别大会结果。
- 私有化可能性： OUE Limited持股比例高，未来若有私有化提议，或将以溢价收购，值得投资者密切关注。
- 资产估值披露： 公司部分海外资产未反映在合并报表中，或导致市场低估公司实际价值。
- 扩张及战略合作： 公司持续扩张及布局专科与综合医疗，有望提升营收及市场地位，支持长期价值增长。
其他须知事项
- 股东大会采用电子投票，提升透明度与效率。
- 未收到任何股东提前或现场提问，显示投资者对公司信息披露较为满意或较为被动。
- 会议纪要将公开发布，保障信息透明。
结论
OUE Healthcare Limited正通过战略合作、区域扩张及医疗创新稳步推进发展。First REIT资产出售带来的潜在特别股息及大股东私有化可能性，是短期内投资者需重点关注的事项。公司轻资产战略及复杂市场下的成功运营，为未来价值创造奠定基础。
免责声明：本报道仅供参考，不构成任何投资建议或买卖证券的推荐。投资者须自行甄别风险，必要时请咨询专业顾问。
